0001193125-15-350693.txt : 20151022 0001193125-15-350693.hdr.sgml : 20151022 20151022160304 ACCESSION NUMBER: 0001193125-15-350693 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20151022 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151022 DATE AS OF CHANGE: 20151022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUALITY SYSTEMS, INC CENTRAL INDEX KEY: 0000708818 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 952888568 STATE OF INCORPORATION: CA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12537 FILM NUMBER: 151170294 BUSINESS ADDRESS: STREET 1: 18111 VON KARMAN AVENUE STREET 2: SUITE 700 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 949-255-2600 MAIL ADDRESS: STREET 1: 18111 VON KARMAN AVENUE STREET 2: SUITE 700 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: QUALITY SYSTEMS INC DATE OF NAME CHANGE: 19920703 8-K 1 d72470d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report

(Date of earliest event reported):

October 22, 2015

 

 

QUALITY SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

CALIFORNIA   001-12537   95-2888568

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification Number)

18111 Von Karman, Suite 700

Irvine, California 92612

(Address of Principal Executive Offices)

(949) 255-2600

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 8.01 Other Events.

On October 22, 2015, Quality Systems, Inc. (the “Company”) issued a press release announcing that it has sold the Hospital Solutions Division of its NextGen Healthcare subsidiary to QuadraMed Affinity Corporation, which is part of the Harris Operating Group of Constellation Software Inc., for undisclosed financial terms. A copy of the press release is attached to this Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No.

   

Description

99.1    Press Release dated October 22, 2015

 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: October 22, 2015     QUALITY SYSTEMS, INC.
    By:  

/s/ Jocelyn A. Leavitt

      Jocelyn A. Leavitt
     

Executive Vice President, General

Counsel and Secretary

 

3

EXHIBITS ATTACHED TO THIS REPORT ON FORM 8-K

 

Exhibit No.

   

Description

99.1    Press Release dated October 22, 2015
 EX-99.1 2 d72470dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Quality Systems, Inc. | Page 1

 

LOGO

QUALITY SYSTEMS, INC. BOARD OF DIRECTORS APPROVES SALE OF NEXTGEN

HEALTHCARE HOSPITAL SOLUTIONS DIVISION

Irvine, Calif. – October 22, 2015 – Quality Systems, Inc. (NASDAQ: QSII), announced today it has sold the Hospital Solutions Division of its NextGen Healthcare subsidiary to QuadraMed Affinity Corporation (“QuadraMed”), which is part of the Harris Operating Group of Constellation Software Inc.

QuadraMed provides healthcare software and services primarily used in hospitals, health systems and related facilities throughout the U.S., Canada, the United Kingdom, and Saudi Arabia.

“The divestiture of our Hospital Solutions Division enables Quality Systems and NextGen Healthcare to focus on our core, ambulatory business, which includes one of the largest installed bases in the industry. This transaction underscores our commitment to further cementing our market position and emphasizing our core strengths within the ambulatory segment of healthcare delivery,” said Rusty Frantz, Quality Systems’ president and CEO.

Additional details will be communicated to NextGen Healthcare Solutions clients as well as employees as part of a seamless transition to QuadraMed.

The Spartan Group LLC provided financial advisory services to Quality Systems in this transaction.

About QuadraMed

Founded in 1993, QuadraMed® is a leading provider of healthcare technologies and services that improve the safety, quality and efficiency of patient care. Behind the Company’s products and services is a staff of 475 professionals who support clients at over 1,200 healthcare facilities. For information about QuadraMed, visit www.quadramed.com.

About Quality Systems, Inc.

Irvine, Calif.-based Quality Systems, Inc. and its NextGen Healthcare subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices. Visit www.qsii.com and www.nextgen.com for additional information.

Quality Systems, Inc. | Page 2

Contacts:

For Media and Public Relations Inquiries Contact:

NextGen Healthcare

Michelle Rovner, 215-657-7010

mrovner@nextgen.com

QuadraMed

Anand Savani

Weber Shandwick

617-520-7120

asavani@webershandwick.com

For Investor Relations Inquiries Contact:

Quality Systems, Inc.

Susan J. Lewis, 954-389-3700

slewis@qsii.com

Quality Systems, Inc.

John Stumpf, 949-255-2600

Interim CFO

jstumpf@qsii.com

Certain statements in this news release are forward-looking statements within the meaning of the federal securities laws, including but not limited to those statements made by Rusty Frantz related to the Company’s future products and offerings and those statements by Rusty Frantz related to developments and trends in the healthcare industry and the Company’s future products and offerings. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company’s expectations and projections. Factors that could cause the anticipated results to differ from those described in the forward-looking statements include the possibility that products will not achieve or sustain market acceptance; the impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in our software; changing economic, political or regulatory influences in the healthcare industry; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company’s ability or inability to attract and retain qualified personnel; possible regulation of the Company’s software by the U.S. Food and Drug Administration; and general economic conditions. Additional risks and uncertainties are set forth in the Company’s public filings with the U.S. Securities and Exchange Commission, including the discussion under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. The Company expressly disclaims any intent or obligation to update these forward-looking statements except as required by law.

© 2015 Quality Systems, Inc., Irvine, CA 92612

® Marks owned by Quality Systems, Inc.

GRAPHIC 3 g72470img002.jpg GRAPHIC begin 644 g72470img002.jpg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end